Skip to Content Facebook Feature Image

NCCN Commits to Sharing Award-Winning Resources for People with Cancer in Spanish and Other Languages

Business

NCCN Commits to Sharing Award-Winning Resources for People with Cancer in Spanish and Other Languages
Business

Business

NCCN Commits to Sharing Award-Winning Resources for People with Cancer in Spanish and Other Languages

2024-09-12 09:02 Last Updated At:09:25

Translations are underway for the entire library of NCCN Guidelines for Patients to empower people with cancer and caregivers worldwide to make informed treatment decisions that are best for them.

PLYMOUTH MEETING, Pa., Sept. 12, 2024 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—and the NCCN Foundation® proudly announce plans to make every book in the library of NCCN Guidelines for Patients® available in Spanish; with select editions available in additional languages as well.

NCCN publishes the NCCN Guidelines for Patients library through funding from the NCCN Foundation. It now features more than 70 books with easy-to-understand information about prevention, screening, diagnosis, treatment, and supportive care for nearly every type of cancer. The patient guidelines are based on the continuously updated, evidence-based, expert consensus-driven recommendations from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) which are used by health care providers worldwide. They have been recognized with numerous awards as a trustworthy and user-friendly source of information for people with cancer.

The NCCN Guidelines for Patients are available to view or download for free online at NCCN.org/patientguidelines or via the NCCN Patient Guides for Cancer App. Non-English editions can also be found at NCCN.org/global. Printed books are available for a nominal fee via Amazon.

"Our commitment to making sure every patient guideline is available in Spanish showcases our dedication to ensuring everyone can access high-quality cancer care resources," said Gena Cook, Founder & CEO, Kaliper Health, Chair, NCCN Foundation Board of Directors. "Our work is already well underway, with at least 20 books available in Spanish right now, and more to come. We have a list of additional high-priority languages based on global population representation. We want to make sure this vital information is understandable for everyone who needs it worldwide, including non-English speakers with cancer within the United States."

All translations are completed by interpreters who specialize in medical texts and understand the nuances of healthcare information. In addition to Spanish, there are currently NCCN Guidelines for Patients available in:

"The NCCN Guidelines for Patients were accessed more than 1.4 million times last year with about a fifth of those users located outside the United States," said Crystal S. Denlinger, MD, Chief Executive Officer, NCCN. "We always strive to improve how we deliver crucial health guidance and expand the reach for any resources that can help us improve and facilitate quality, effective, equitable, and accessible cancer care worldwide."

Patrick Delaney, Executive Director, NCCN Foundation, added: "The NCCN Foundation is fortunate to be able to collaborate with a diverse group of international organizations who recognize the need for equitable access to cancer patient information. We are incredibly grateful for the philanthropic support that makes it possible for us to offer these essential resources free-of-charge for all who need them."

The NCCN website also features several resources for people facing cancer and caregivers, including live and recorded webinars, suggested questions to ask health care providers, links to advocacy and support groups, and much more. Visit NCCN.org/patients to learn more or go to NCCNFoundation.org to help support the mission.

About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, equitable, and accessible cancer care so all patients can live better lives. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) provide transparent, evidence-based, expert consensus recommendations for cancer treatment, prevention, and supportive services; they are the recognized standard for clinical direction and policy in cancer management and the most thorough and frequently-updated clinical practice guidelines available in any area of medicine. The NCCN Guidelines for Patients® provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation®. NCCN also advances continuing education, global initiatives, policy, and research collaboration and publication in oncology. Visit NCCN.org for more information.

About the NCCN Foundation
The NCCN Foundation empowers people with cancer and their caregivers by delivering unbiased expert guidance from the world's leading cancer experts through the library of NCCN Guidelines for Patients® and other patient education resources. The NCCN Foundation is also committed to advancing cancer treatment by funding the nation's promising young investigators at the forefront of cancer research. For more information about the NCCN Foundation, visit nccnfoundation.org.

Media Contact:
Rachel Darwin
267-622-6624
darwin@nccn.org

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

NCCN Commits to Sharing Award-Winning Resources for People with Cancer in Spanish and Other Languages

NCCN Commits to Sharing Award-Winning Resources for People with Cancer in Spanish and Other Languages

EMURGO connects the Zilliqa ecosystem to the Cardano ecosystem through a variety of interoperability and economic security-focused initiatives.

SINGAPORE, Sept. 17, 2024 /PRNewswire/ -- EMURGO, a blockchain technology company that facilitates commercial adoption of the Cardano blockchain, today announced a strategic partnership with the Zilliqa Group, a Web3 and metaverse venture builder for the luxury and entertainment industries that leverages leading-edge Web3 technologies across its ventures, including the Zilliqa blockchain. The partnership focus extends beyond interoperability between the Cardano and Zilliqa blockchains and will also include mutual collaboration in the following areas:

As part of this strategic collaboration, Zilliqa Group will join Intersect (Cardano governance member-based organization), and become a part of Cardano's globally distributed community in helping to shape Cardano's governance processes.

EMURGO COO Nikhil Joshi said, "This collaboration with Zilliqa underscores EMURGO's commitment to enhancing interoperability with the Cardano ecosystem and supporting the diversification of its community-driven governance. We are pleased to work with an established blockchain network across the usage of our solutions and bridge Zilliqa into the Cardano ecosystem to further strengthen liquidity and adoption for the benefit of users and developers."

Zilliqa Group CEO Max Kantelia said: "Partnering with EMURGO and the Cardano ecosystem represents a major step forward in our mission to build a more inclusive, scalable, and accessible blockchain future. By focusing on interoperability, we ensure that users and apps across both the Zilliqa and Cardano networks benefit from enhanced liquidity, governance, and shared innovation. This collaboration is a powerful reminder that the future of blockchain is a collaborative effort, and we're excited to be at the forefront of this cooperative approach to Web3."

These steps demonstrate that the bridge between the Zilliqa and Cardano networks is not just a technical step towards greater interoperability, but marks a shift in Web3 mentality that puts distributed blockchain governance and the user experience first.

About EMURGO

EMURGO is a blockchain technology company and a founding entity of the Cardano blockchain that provides products and services to drive the adoption of Cardano's Web3 ecosystem. Originally established in Japan, EMURGO exists to facilitate commercial growth of the Cardano ecosystem and unlock the full potential of the ecosystem through partnerships, investments, education, and infrastructure development.

To connect and learn more, visit https://emurgo.io.

About Zilliqa Group

Zilliqa Group is a Web3 venture builder with entities focusing on innovating the luxury and entertainment industries, embracing a federated leadership model that allows entrepreneurs to concentrate on innovation and rapid execution. Zilliqa Group ventures include the Zilliqa layer-1 blockchain, metaverse and spatial web provider MetaMinds, music tokenisation platform TokenTraxx, and Web3 gaming company Roll1ng Thund3rz.

Zilliqa is an industry-recognised layer-1 blockchain that provides a robust platform for developers and enterprises. The pioneering blockchain platform aims to drive the mass adoption of Web3 through its upcoming, user-centric Zilliqa 2.0 network upgrade. Currently rolling out testnet with the mainnet launch in Q4'2024. Join early developers and validators in testing the network at https://roadmap.zilliqa.com.

To connect and learn more, visit https://www.zilliqa.group.

Disclaimer

You should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained herein shall constitute a solicitation, recommendation, endorsement, or offer by EMURGO to invest.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

EMURGO and Zilliqa Group Announce Collaboration to Enhance Interoperability Between Cardano and Zilliqa

EMURGO and Zilliqa Group Announce Collaboration to Enhance Interoperability Between Cardano and Zilliqa

Recommended Articles